跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
PHARMACOR GLICLAMIRON gliclazide 30 mg modified release tablet bottle pack
Approved
STANDARD
PHARMACOR GLICLAMIRON gliclazide 30 mg modified release tablet bottle pack
Pharmacor Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d1507860ced9e3a8
Company
Pharmacor Pty Ltd
Type
Standard
Approval Details
Approval Id
d1507860ced9e3a8
Product Name
PHARMACOR GLICLAMIRON gliclazide 30 mg modified release tablet bottle pack
Artg Id
316925
Artg Name
PHARMACOR GLICLAMIRON gliclazide 30 mg modified release tablet bottle pack
Sponsor
Pharmacor Pty Ltd
Company Detail Path
/organization/pharmacor-sa-pty-ltd
Artg Date
2020-04-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b9c71f27951843808baafe4be091fb05.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/4104997879fc012e3718037b79673030.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d1507860ced9e3a8
Type
Standard
Back to TGA Approvals
PHARMACOR GLICLAMIRON gliclazide 30 mg modified release tablet bottle pack - TGA Drug Approval Details
